Improved therapies are needed against snakebite envenoming, which kills and permanently
disables thousands of people each year. Recently developed neutralizing monoclonal …

Snakebite envenoming is a major global public health concern for which improved therapies
are urgently needed. The antigenic diversity present in snake venom toxins from various …

Snakebite is a neglected tropical disease that causes high rates of global mortality and
morbidity. Although snakebite can cause a variety of pathologies in victims, haemotoxic …

Snakebite envenoming continues to claim many lives across the globe, necessitating the
development of improved therapies. To this end, broadly-neutralizing human monoclonal …

Broadly-neutralizing monoclonal antibodies are of high therapeutic utility against infectious
diseases caused by bacteria and viruses, as well as different types of intoxications …

Animal toxins present a major threat to human health worldwide, predominantly through
snakebite envenomings, which are responsible for over 100,000 deaths each year. To date …

Snake envenoming is a globally neglected public health problem. Antivenoms produced
using animal hyperimmune plasma remain the standard therapy for snakebites. Although …

Snakebite envenomation is considered a neglected tropical disease, affecting tens of
thousands of people each year. The recommended treatment is the use of antivenom, which …

Antivenoms, produced using animal hyperimmune plasma, remains the standard therapy for
snakebites. Although effective against systemic damages, conventional antivenoms have …

With an annual 5 million cases, 150,000 deaths, and about 400,000 amputations, snakebite
envenoming is an ever-present threat in many parts of the rural tropical world. Parental …